Skip to main content
All lobbying clients

ALLIANCE FOR PHARMACY COMPOUNDING

Lobbying client · Texas · filed 2025 to 2026

Non-profit association promoting the practice of pharmacy compounding

$350,000 Reported spend
7 Filings counted
1 Outside firm hired
4 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page comes from one LDA client record (123115), filed by the registrant listed below.

 Who filed for this client 1

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 4
  • H.R. 5316
    Drug Shortage Compounding Patient Access Act of 2025
    3 filings
  • H.R. 6509
    SAFE Drugs Act of 2025
    3 filings
  • S. 3794
    SAFE Drugs Act of 2026
    3 filings
  • H.R. 167
    Patient Access to Urgent-Use Pharmacy Compounding Act of 2023
    1 filing
 Reported by year 2 years
  • 2026 $150,000 3 filings
  • 2025 $200,000 4 filings
 Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 3
  • HOUSE OF REPRESENTATIVES 7
  • SENATE 7
  • Food & Drug Administration (FDA) 1

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem